EVAg

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) as of Jan 30, 2020, available from https://www.mdpi.com/1999-4915/12/2/159/pdf. Primers and Probe sequences designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 24 rxns in the form of 3x8 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the RdRp gene. Primers and Probe sequences designed by Charité Universitätsmedizin Berlin. https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the RdRp (IP4) gene. Primers and Probe sequences designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the N (CUB) gene. Primers and Probe sequences designed by Charité Universitätsmedizin Berlin; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf). SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/CBA, BA.2.86.1, France 2023, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/RKL, GS.1.4, France 2023, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/SeCO, XBB.1.16, France 2023, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/CCO, XBB.1.16.11, France 2023, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/GGR, EG.5.1, France 2023, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2023/FR/ADP, XBB.1.9.1, France 2023, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/ACO, XBB.2, France 2022, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/4933, BF.7, France 2022, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/LPE, BQ.1.1, France 2022, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/GPO, Omicron BA.5, France 2022, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2022/FR/TCO, Omicron BA.2, France 2022, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/1514, Omicron, France 2021, complete genome sequence

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/CO/6600 (Mu), Colombia 2021 ,complete genome sequence

SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2021/FR/X1 (Lineage B 1.617.2, Delta) France 2021, complete genome sequence. Absence of spike mutation in A222

Freeze-dried SARS-CoV-2 virus, strain SARS-CoV-2/2021/FR/0610 (Lineage B 1.617.2, Delta) France 2021, complete genome sequence. Presence of spike mutation A222V and absence of spike mutation Y145H.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1572 in the spike coding sequence) of the SARS-CoV-2 alpha variant (B.1.1.7) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1517 in the spike coding sequence) of the SARS-CoV-2 beta variant (B.1.351 )and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1581 in the spike coding sequence) of the SARS-CoV-2 BavPat1 strain (D614G) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1581 in the spike coding sequence) of the SARS-CoV-2 delta variant (B.1.617.2) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD of the SARS-CoV-2 gamma variant (P.1) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

Freeze-dried SARS-CoV-2 virus, strain UVE/SARS-CoV-2/2020/FR/702, France 2020, complete genome sequence. NB: this virus contains the G614 european mutation in the spike sequence